Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials
Authors:
Open Access
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (6) , 1133-1137
Abstract
No abstract availableKeywords
Funding Information
- Washington University Institute of Clinical and Translational Sciences (UL1 TR000448)
- National Heart, Lung, and Blood Institute (U10HL069294)
- National Cancer Institute
- University of Minnesota Cancer Center (P30CA077598)
This publication has 30 references indexed in Scilit:
- Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid TreatmentTransplantation and Cellular Therapy, 2013
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2012
- Mesenchymal Stromal Cells: A New Tool against Graft-versus-Host Disease?Transplantation and Cellular Therapy, 2012
- Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial systemBlood, 2011
- Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2010
- A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2009
- Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialBlood, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host diseaseTransplantation and Cellular Therapy, 2000
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986